| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10748552 | Biochemical and Biophysical Research Communications | 2016 | 8 Pages |
Abstract
We conclude that the Akt pathway inhibitor NSC156529 is potentially useful as single treatment for liver tumors with hyperactivated Akt signaling.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Biochemistry
Authors
Kristina Mäemets-Allas, Denis BelitÅ¡kin, Viljar Jaks,